Clinical Study
Evaluation of Histopathological Changes in Control Biopsies Which Taken 48 Sessions after NBUVB Phototherapy for Early-Stage Mycosis Fungoides
Table 2
Evaluation of parameters after the treatment, according to response to treatment.
| | Response to treatment | | After treatment | Yes | No | | | (%) | (%) | |
| Epidermotropism | | | | Single/haloed lymphocytes | 3 (13.0%) | 4 (44.4%) | 0.053 | Linearly arranged | 2 (8.7%) | 4 (44.4%) | 0.038* | lymphocytes | | | | Pautrier microabscesses | 1 (4.3%) | 3 (33.3%) | 0.057 | Stratum corneum | | | | Normal | 19 (82.6%) | 2 (22.2%) | 0.001** | Parakeratosis | 0 (0.0%) | 1 (11.1%) | 0.281 | Orthohyperkeratosis | 4 (17.4%) | 6 (66.7%) | 0.007** | Epidermis | | | | Normal | 13 (56.5%) | 2 (22.2%) | 0.122 | Atrophic | 7 (30.4%) | 1 (11.1%) | 0.256 | Hyperplastic | 3 (13.0%) | 6 (66.7%) | 0.002** | Inflammatory infiltrates | | | | Superficial. perivascular | 13 (52.1%) | 4 (44.4%) | 0.433 | Lichenoid/patchy lichenoid | 2 (8.7%) | 5 (55.6%) | 0.004** | No inflammation | 9 (39.1%) | 0 (0%) | 0.027* | Fibrosis | | | | 0 | 6 (26.1%) | 0 (0.0%) | 0.150 | 1 | 15 (65.2%) | 7 (77.8%) | 0.491 | 2 | 1 (4.3%) | 2 (22.2%) | 0.184 | Other changes | | | | Basal vacuolar degeneration | 7 (30.4%) | 0 (0.0%) | 0.061 | Dyskeratotic cells | 7 (30.4%) | 0 (0.0%) | 0.061 | Melanophages | 18 (78.3%) | 5 (55.6%) | 0.199 | Vascular changes | | | | Telangiectasia | 10 (43.5%) | 4 (44.4%) | 0.960 | Vascular proliferation | 3 (13.0%) | 1 (11.1%) | 1.000 |
|
|
Chi-square and Fisher's Exact tests were used *P < 0.05, **P< 0.01.
|